Elikem Pharmaceuticals Private Limited

Elikem Pharmaceuticals Private Limited - pharma in Kalol, Gujarat, India. FY 2026 financials & compliance.
CIN U24231GJ1992PTC018162 Incorporated 17 August 1992 ROC Ahmedabad HQ Kalol, Gujarat, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹26.94 Cr
▲ 14% YoY
Net profit · FY 2025
₹29.72 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹85.97 Lakh
EBITDA margin 3.2%
Authorised capital
₹12.5 Lakh
Registered with MCA
Paid-up capital
₹12.5 Lakh
Issued & subscribed
Open charges
₹3.86 Cr
Satisfied ₹1.35 Cr
Company age
34 yrs
Est. 1992
Directors on board
4
As per MCA filings

About Elikem Pharmaceuticals Private Limited

Data last updated:

Elikem Pharmaceuticals Private Limited is a private limited company based in Kalol, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 August 1992 and has been in existence for over 34 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1992PTC018162. Its GSTIN is 24AAACE6814H1ZW (Gujarat).

The company has an authorised share capital of ₹12.5 Lakh and a paid-up capital of ₹12.5 Lakh. It is led by directors including Prakashkumar Shivramdas Patel and Vasantbhai Ambalal Raval.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Kalol, Gujarat.

As per the financials filed for FY 2025, the company reported a revenue of ₹26.94 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹29.72 Lakh (net margin 1.1%) and EBITDA of ₹85.97 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 22% over five years.

The company is associated with 1 brand: Elikem Pharmaceuticals. As per MCA filings, the company has open charges of ₹3.86 Cr and satisfied charges of ₹1.35 Cr on record. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it.

Elikem Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0028125). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elikempharma.com.

Company details

CIN U24231GJ1992PTC018162
Registration Number 018162
Incorporation Date 17 August 1992
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0028125

Recognitions & Rankings of Elikem Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-01-0028125

Contact details

Elikem Pharmaceuticals Private Limited's registered office is in Kalol, Gujarat. Its website is elikempharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Elikem Pharmaceuticals Pvt. Ltd. Plot No : 816/1 At : Rakanpur Tal : Ka, Lol, Kalol, Gujarat, India – 382721
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Elikem Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Elikem Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Elikem Pharmaceuticals operates one associated brand: Elikem Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing and exporting pharmaceuticals and nutraceuticals from India.elikempharma.com

Business activity

The main business activity of Elikem Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Elikem Pharmaceuticals Private Limited, buy the company report.

Financials of Elikem Pharmaceuticals Private Limited

FY 2024 filings available

Elikem Pharmaceuticals Private Limited reported revenue of ₹26.94 Cr (up 14% YoY) for FY 2025.

Revenue · FY 2025
₹26.94 Cr ▲ 14%
Net profit · FY 2025
₹29.72 Lakh margin 1.1%
EBITDA · FY 2025
₹85.97 Lakh margin 3.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 17%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 19%
5 years · compounded
▲ 14%

Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 14% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹85.97 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹29.72 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.2%
Net Profit Margin1.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Elikem Pharmaceuticals Private Limited, buy the company report.

Board of directors of Elikem Pharmaceuticals Private Limited

Elikem Pharmaceuticals has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Prakashkumar Shivramdas PatelDirector01 Apr 201016 Years 7 MonthsCurrent
Vasantbhai Ambalal RavalDirector16 Jun 201412 Years 4 MonthsCurrent
Chirag Girishbhai PatelDirector01 Apr 200521 Years 7 MonthsCurrent
Pratik Girishbhai PatelDirector01 Apr 200521 Years 7 MonthsCurrent

Peer comparison

Elikem Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
HBC Healthcare Private Limited₹27.06 Cr (FY 2024)288.0%Gandhinagar, Gujarat, India
Aurio Pharma Laboratories Private Limited₹27.02 Cr (FY 2025)-9.0%Kolkata, West Bengal, India
Orley Laboratories Private Limited₹27.02 Cr (FY 2025)19.0%Ahmedabad, Gujarat, India
God Gift Laboratory Private Limited₹26.95 Cr (FY 2025)-7.0%Punjabi Bagh, Delhi, India
Elikem Pharmaceuticals Private Limitedthis company₹26.94 Cr (FY 2025)₹29.72 Lakh1.1%14.0%Kalol, Gujarat, India
Nysa Biomed Private Limited₹26.79 Cr (FY 2025)33.0%Satara, Maharashtra, India
Truelixir Life Science Private Limited₹26.74 Cr (FY 2024)85.0%Aurangabad, Maharashtra, India

To see the full peer comparison of Elikem Pharmaceuticals Private Limited, buy the company report.

Auditor

Elikem Pharmaceuticals Private Limited is audited by Shailesh C. Parikh & Co. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Shailesh C. Parikh & Co.FY 2024109858W

Shareholding

The shareholding of Elikem Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Elikem Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹3.86 Cr
Satisfied charges
₹1.35 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹3.16 Cr
Sidbi₹0.70 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Jul 2023100756296Hdfc Bank Limited₹25 LakhOpen
26 Sep 2022100615177Hdfc Bank Limited₹9 LakhOpen
09 Aug 2021100466875Sidbi₹70 LakhOpen
30 Nov 2020100392251Hdfc Bank Limited₹2.82 CrOpen
02 Jun 2020100338073Sidbi₹50 LakhSatisfied

To see the full charge records of Elikem Pharmaceuticals Private Limited, buy the company report.

Total charge records: 9 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Elikem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Elikem Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAACE6814H1ZWGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Elikem Pharmaceuticals Private Limited, buy the company report.

Recent activity

Elikem Pharmaceuticals Private Limited has 12 board changes on record since 2005: 4 appointments and 8 cessations. The latest: Jigna Vipulbhai Patel ceased to be Additional Director on 29 Sep 2018.

AGM
Elikem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Elikem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge with Hdfc Bank Limited of Rs. 282.00 Lakh registered on 30 Nov 2020 with Charge ID 100392251 was modified on 22 Nov 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.00 Lakh with Charge ID 100756296 was registered on 29 Jul 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 9.00 Lakh with Charge ID 100615177 was registered on 26 Sep 2022.
Charges
A charge registered on 02 Jun 2020 via Charge ID 100338073 with Sidbi was fully satisfied on 24 Dec 2021.
Charges
A charge with Sidbi amounted to Rs. 70.00 Lakh with Charge ID 100466875 was registered on 09 Aug 2021.
Charges
A charge registered on 04 Jan 2016 via Charge ID 10621084 with The Kalol Nagarik Sahakari Bank Limited was fully satisfied on 19 Dec 2020.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 282.00 Lakh with Charge ID 100392251 was registered on 30 Nov 2020.
Charges
A charge registered on 10 Mar 2017 via Charge ID 100094793 with Others was fully satisfied on 08 Jun 2020.
Charges
A charge with Sidbi amounted to Rs. 50.00 Lakh with Charge ID 100338073 was registered on 02 Jun 2020.
Ceased
Jigna Vipulbhai Patel ceased to be Additional Director.

19 earlier events are in the company report.

Frequently asked questions

Elikem Pharmaceuticals is an active private limited company based in Kalol, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 August 1992 (34+ years old) and is registered under CIN U24231GJ1992PTC018162.

Elikem Pharmaceuticals has 4 current directors:

The latest financial statements of Elikem Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Elikem Pharmaceuticals is 24AAACE6814H1ZW, registered in Gujarat.

The CIN (Corporate Identification Number) of Elikem Pharmaceuticals is U24231GJ1992PTC018162. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Elikem Pharmaceuticals has 6 court cases on record: 2 filed by the company and 4 filed against it.

Elikem Pharmaceuticals was incorporated on 17 August 1992, making it 34+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Elikem Pharmaceuticals by revenue are HBC Healthcare Private Limited, Aurio Pharma Laboratories Private Limited, Orley Laboratories Private Limited, God Gift Laboratory Private Limited, Nysa Biomed Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Jigna Vipulbhai Patel ceased to be Additional Director on 29 Sep 2018. Laxmanbhai Ambalal Patel ceased to be Director on 01 Apr 2016. Vinodkumar Ambalal Patel ceased to be Director on 01 Apr 2016. Elikem Pharmaceuticals has 12 board changes on record in total.

Yes, Elikem Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0028125).

Elikem Pharmaceuticals can be reached through the website elikempharma.com. Its registered office is in Kalol, Gujarat, India.